PARDO GEOFFREY B purchased 16.7% of their position (312.50K shares) of SPYGLASS PHARMA, INC. on the open market
Open‑market purchase worth $5.00M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/11/2026ACC: 0001753143-26-000006
+312.50K
Net shares
Net buyer
$5.00M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
2.19M acquired · 1.88M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.88M
Price / share
—
Trade value
—
% of position
New position
2/9/2026
0.00→1.88M
Common Stock
Indirect
Shares
+312.50K
Price / share
$16.00
Trade value
$5M
% of position
16.7%
2/9/2026
1.88M→2.19M
Total
Net shares
+2.19M
Net value
$5M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/9/2026 | C · Conversion | +1.88M | — | — | New position | 0.00 | 1.88M |
| Common Stock Indirect | 2/9/2026 | P · Purchase | +312.50K | $16.00 | $5M | 16.7% | 1.88M | 2.19M |
| Total | +2.19M | $5M | ||||||
Derivative Transactions1
Series D Preferred Stock
Indirect
Converts to
Common Stock
1.88M shares
Shares
−1.88M
Strike price
Held after
0.00
Exercisable
—
2/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series D Preferred Stock Indirect | Common Stock1.88M shares | 2/9/2026 | C · Conversion | −1.88M | — | 0.00 |